Add Vitamin C : This vitamin makes Glutathione even stronger, especially for skin glow
My Take: With this FDA nod, Novo Nordisk cements its dominance in the GLP-1 revolution, transforming chronic disease management from diabetes control to comprehensive cardiovascular protection
Other Prescription Weight Loss Medications While GLP-1s dominate, other FDA-approved medications exist for patients who cant use GLP-1s or prefer alternatives
annually causes significant RAF loss for MA plans (~0.519 per patient per year)
Retatrutide goes one step further by adding glucagon receptor activity, but it remains investigational
Semaglutide selectively activates the GLP-1 receptor, producing: Glucose-dependent insulin secretion : Reduces hypoglycemia risk compared to non-incretin agents Glucagon suppression : Reduces hepatic glucose output in the hyperglycemic state Gastric emptying delay : Contributes to postprandial glucose control and satiety Central appetite regulation : Acts on GLP-1 receptors in the hypothalamus and brainstem to reduce hunger and alter food preferences The simplicity of semaglutide's single-receptor mechanism is both a limitation (no energy expenditure enhancement from glucagon) and a strength (thoroughly understood pharmacology, predictable effects, extensive safety characterization)